- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | Glucotrack announces 1-for-15 reverse stock split | 1 | Seeking Alpha | ||
| 27.08. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.08. | Glucotrack, Inc. Announces Reverse Stock Split | 243 | Business Wire | 1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack"... ► Artikel lesen | |
| 19.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.08. | Glucotrack regains Nasdaq compliance on equity requirement | 1 | Investing.com | ||
| 06.08. | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | 1 | pulse2.com | ||
| 05.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 17.07. | Glucotrack Gains Slightly on Bridge Financing Deal | - | Baystreet.ca | ||
| 17.07. | Glucotrack completes bridge financing after merger | 1 | Investing.com | ||
| 17.07. | Glucotrack schließt Brückenfinanzierung nach Unternehmenszusammenschluss ab | 2 | Investing.com Deutsch | ||
| 17.07. | GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On | 2 | Benzinga.com | ||
| 16.07. | Glucotrack completes business combination with Lokahi Therapeutics | 3 | Investing.com | ||
| 15.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.07. | Glucotrack combines with Lokahi Therapeutics to become CBGM subsidiary | - | MassDevice | ||
| 14.07. | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | 313 | GlobeNewswire (Europe) | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| 27.05. | Glucotrack CEO explains tech behind long-term CBGM implant | 12 | MassDevice | ||
| 15.05. | Glucotrack reports Q1 results | 1 | Seeking Alpha | ||
| 14.05. | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | 650 | GlobeNewswire (Europe) | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| 14.05. | Glucotrack, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,850 | +0,47 % | Eckert & Ziegler: Innovationsführer im Strahlentherapie-Markt etabliert sich weiter | ||
| TELADOC HEALTH | 5,396 | -0,15 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| SERNOVA BIOTHERAPEUTICS | 0,065 | -7,39 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | 0,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| HEALWELL AI | 0,493 | -2,28 % | Healwell AI Inc: Healwell AI to roll out Smart tools on Iowa HIE | ||
| ATOSSA THERAPEUTICS | 2,160 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| UNIDOC HEALTH | 0,053 | -13,20 % | UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform | Proposed collaboration would combine UniDoc's connected-care infrastructure with Ventripoint's AI-enabled cardiac imaging platform VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| TANDEM DIABETES | 17,500 | +1,74 % | Aus TNDM Trucking wird Girteka Dedicated | ||
| CO-DIAGNOSTICS | 1,160 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUIDELORTHO | 11,790 | -1,95 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 206,10 | +0,98 % | Renalytix PLC - Collaboration with Quest Diagnostics |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,67 % bei einem Aktienkurs von 2,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.